
The updated vaccine will be available to eligible groups as part of the 2026/27 NHS vaccination programme

The mRNA-based therapy, used with Keytruda, is designed specifically for each patient

Mukherjee has previously held senior leadership roles at Moderna and GSK

Skin cancer is one of the most common cancers in the US, with melanoma accounting for the majority of skin cancer deaths

The study aims to enrol 2,850 participants across 16 sites in Europe

Global health authorities have recommended that vaccines for the 2025-2026 season should target LP.8.1

More than 600,000 people in the US were hospitalised due to flu-related illness last year

The vaccine is already approved in the US for use in adults aged 60 years and older

The deal will support the advancement of BioNTech’s mRNA-based cancer immunotherapies

RSV is responsible for 14,000 hospitalisations per year in UK adults aged 65 years and older

The combined vaccine approach could simplify immunisation practices and lead to higher uptake

The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be challenging for influenza studies, especially given the typically short patient...